2025-04-14 10:29:43
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Vivo Bio Tech Ltd Q4FY22 consolidated loss at Rs. 68.71 lakhs
Posted On : 2022-06-08 14:06:45( TIMEZONE : IST )
VIVO BIO TECH LTD. has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 15.1528 crores during the period ended March 31, 2022 as compared to Rs. 12.9202 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -0.6871 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.3721 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -0.49 for the period ended March 31, 2022 as compared to Rs. 0.93 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 15.1528 crs | ₹12.9202 crs |  17.28% |
| Net Profit | ₹-0.6871 crs | ₹1.3721 crs |  -150.08% |
| EPS | ₹-0.49 | ₹0.93 | -152.69% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 15.1528 crores during the period ended March 31, 2022 as compared to Rs.16.1599 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-0.6871 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.0.2975 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-0.49 for the period ended March 31, 2022 as compared to Rs.0.22 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 15.1528 crs | ₹16.1599 crs | -6.23% |
| Net Profit | ₹-0.6871 crs | ₹0.2975 crs | -330.96% |
| EPS | ₹-0.49 | ₹0.22 | -322.73% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.51.4893 crores during the Financial Year ended March 31, 2022 as compared to Rs.51.8538 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.2.2016 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.5.6823 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.1.56 for the Financial Year ended March 31, 2022 as compared to Rs.4.19 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹51.4893 crs | ₹51.8538 crs | -0.70% |
| Net Profit | ₹2.2016 crs | ₹5.6823 crs | -61.26% |
| EPS | ₹1.56 | ₹4.19 | -62.77% |
Shares of VIVO BIO TECH LTD. was last trading in BSE at Rs. 37.50 as compared to the previous close of Rs. 37.95. The total number of shares traded during the day was 3486 in over 62 trades.
The stock hit an intraday high of Rs. 38.00 and intraday low of 36.50. The net turnover during the day was Rs. 129918.00.
